 | • レポートコード：QAF27720 • 出版社/出版日：QYResearch / 2021年4月7日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のヒトフィブリノゲン市場について種類別（ピュアヒトフィブリノーゲン、フィブリノーゲン濃縮物（ヒト））、用途別（先天性フィブリノーゲン欠乏症、手術処置用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒトフィブリノゲン市場の概要 ・世界の主要地域別ヒトフィブリノゲン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のヒトフィブリノゲン市場規模2016-2021：種類別（ピュアヒトフィブリノーゲン、フィブリノーゲン濃縮物（ヒト）） ・世界のヒトフィブリノゲン市場予測2012-2027：種類別（ピュアヒトフィブリノーゲン、フィブリノーゲン濃縮物（ヒト）） ・世界のヒトフィブリノゲン市場規模2016-2021：用途別（先天性フィブリノーゲン欠乏症、手術処置用） ・世界のヒトフィブリノゲン市場予測2012-2027：用途別（先天性フィブリノーゲン欠乏症、手術処置用） ・ヒトフィブリノゲンのアメリカ市場規模と予測2016-2021 ・ヒトフィブリノゲンのヨーロッパ市場規模と予測2016-2021 ・ヒトフィブリノゲンの中国市場規模と予測2016-2021 ・ヒトフィブリノゲンの日本市場規模と予測2016-2021 ・ヒトフィブリノゲンの東南アジア市場規模と予測2016-2021 ・ヒトフィブリノゲンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、LFB Group、Shanghai RAAS Blood Products、Jiangxi Boya Bio-Pharmaceutical、Hualan Biological Engineering、Harbin Pacific Biopharmaceutical、GREEN CROSS、Shanghai XinXing Medical、Octapharma） ・ヒトフィブリノゲンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒトフィブリノゲンの市場動向・機会・課題 ・調査の結論 |
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
By product, the global Human Fibrinogen market is segmented into animal Fibrinogen and Human Fibrinogen Concentrate. Animal fibrinogen is still studying to confirm whether it produce toxic effect on human tissues or not after injection, it accounts for majority 0.47% market share of global revenue and Human Fibrinogen Concentrate accounts for majority 99.53% market share of global revenue in 2019.
By end user, the global Human Fibrinogen market is segmented into congenital fibrinogen deficiency and surgical procedures. In 2019, the Surgical Procedures application held the largest share in the global market and accounted for a market share of 91.74%. The Surgical Procedures is major segmented into trauma patients, cardiovascular surgery patients, PPH patients, and plastic surgery patients, accounting for 62.85%, 10.34%, 13.71%, and 1.31% respectively.
CSL is the leaders of the industry, with 52.52% market share of value in 2019, 32.44% market share of volume in 2019 and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
Market Analysis and Insights: Global Human Fibrinogen Market
The global Human Fibrinogen market was valued at US$ 795.8 in 2020 and will reach US$ 1889.2 million by the end of 2027, growing at a CAGR of 15.5% during 2022-2027.
Global Human Fibrinogen Scope and Market Size
The global Human Fibrinogen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Fibrinogen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Pure Human Fibrinogen
Fibrinogen Concentrate (Human)
Segment by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
The Human Fibrinogen market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Fibrinogen market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
1 Human Fibrinogen Market Overview
1.1 Human Fibrinogen Product Scope
1.2 Human Fibrinogen Segment by Type
1.2.1 Global Human Fibrinogen Sales by Type (2016 & 2021 & 2027)
1.2.2 Pure Human Fibrinogen
1.2.3 Fibrinogen Concentrate (Human)
1.3 Human Fibrinogen Segment by Application
1.3.1 Global Human Fibrinogen Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 Human Fibrinogen Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Fibrinogen Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Fibrinogen Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Fibrinogen Price Trends (2016-2027)
2 Human Fibrinogen Estimates and Forecasts by Region
2.1 Global Human Fibrinogen Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Fibrinogen Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Fibrinogen Sales Market Share by Region (2016-2021)
2.2.2 Global Human Fibrinogen Revenue Market Share by Region (2016-2021)
2.3 Global Human Fibrinogen Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Fibrinogen Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Fibrinogen Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Fibrinogen Estimates and Projections (2016-2027)
2.4.2 Europe Human Fibrinogen Estimates and Projections (2016-2027)
2.4.3 China Human Fibrinogen Estimates and Projections (2016-2027)
2.4.4 Japan Human Fibrinogen Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Fibrinogen Estimates and Projections (2016-2027)
2.4.6 India Human Fibrinogen Estimates and Projections (2016-2027)
3 Global Human Fibrinogen Competition Landscape by Players
3.1 Global Top Human Fibrinogen Players by Sales (2016-2021)
3.2 Global Top Human Fibrinogen Players by Revenue (2016-2021)
3.3 Global Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2020)
3.4 Global Human Fibrinogen Average Price by Company (2016-2021)
3.5 Manufacturers Human Fibrinogen Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Fibrinogen Market Size by Type
4.1 Global Human Fibrinogen Historic Market Review by Type (2016-2021)
4.1.1 Global Human Fibrinogen Sales Market Share by Type (2016-2021)
4.1.2 Global Human Fibrinogen Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Fibrinogen Price by Type (2016-2021)
4.2 Global Human Fibrinogen Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Fibrinogen Sales Forecast by Type (2022-2027)
4.2.2 Global Human Fibrinogen Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Fibrinogen Price Forecast by Type (2022-2027)
5 Global Human Fibrinogen Market Size by Application
5.1 Global Human Fibrinogen Historic Market Review by Application (2016-2021)
5.1.1 Global Human Fibrinogen Sales Market Share by Application (2016-2021)
5.1.2 Global Human Fibrinogen Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Fibrinogen Price by Application (2016-2021)
5.2 Global Human Fibrinogen Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Fibrinogen Sales Forecast by Application (2022-2027)
5.2.2 Global Human Fibrinogen Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Fibrinogen Price Forecast by Application (2022-2027)
6 North America Human Fibrinogen Market Facts & Figures
6.1 North America Human Fibrinogen Sales by Company
6.1.1 North America Human Fibrinogen Sales by Company (2016-2021)
6.1.2 North America Human Fibrinogen Revenue by Company (2016-2021)
6.2 North America Human Fibrinogen Sales Breakdown by Type
6.2.1 North America Human Fibrinogen Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Fibrinogen Sales Breakdown by Type (2022-2027)
6.3 North America Human Fibrinogen Sales Breakdown by Application
6.3.1 North America Human Fibrinogen Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Fibrinogen Sales Breakdown by Application (2022-2027)
7 Europe Human Fibrinogen Market Facts & Figures
7.1 Europe Human Fibrinogen Sales by Company
7.1.1 Europe Human Fibrinogen Sales by Company (2016-2021)
7.1.2 Europe Human Fibrinogen Revenue by Company (2016-2021)
7.2 Europe Human Fibrinogen Sales Breakdown by Type
7.2.1 Europe Human Fibrinogen Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Fibrinogen Sales Breakdown by Type (2022-2027)
7.3 Europe Human Fibrinogen Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Human Fibrinogen Market Facts & Figures
8.1 China Human Fibrinogen Sales by Company
8.1.1 China Human Fibrinogen Sales by Company (2016-2021)
8.1.2 China Human Fibrinogen Revenue by Company (2016-2021)
8.2 China Human Fibrinogen Sales Breakdown by Type
8.2.1 China Human Fibrinogen Sales Breakdown by Type (2016-2021)
8.2.2 China Human Fibrinogen Sales Breakdown by Type (2022-2027)
8.3 China Human Fibrinogen Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Human Fibrinogen Market Facts & Figures
9.1 Japan Human Fibrinogen Sales by Company
9.1.1 Japan Human Fibrinogen Sales by Company (2016-2021)
9.1.2 Japan Human Fibrinogen Revenue by Company (2016-2021)
9.2 Japan Human Fibrinogen Sales Breakdown by Type
9.2.1 Japan Human Fibrinogen Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Fibrinogen Sales Breakdown by Type (2022-2027)
9.3 Japan Human Fibrinogen Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Fibrinogen Market Facts & Figures
10.1 Southeast Asia Human Fibrinogen Sales by Company
10.1.1 Southeast Asia Human Fibrinogen Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Fibrinogen Revenue by Company (2016-2021)
10.2 Southeast Asia Human Fibrinogen Sales Breakdown by Type
10.2.1 Southeast Asia Human Fibrinogen Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Fibrinogen Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Fibrinogen Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Human Fibrinogen Market Facts & Figures
11.1 India Human Fibrinogen Sales by Company
11.1.1 India Human Fibrinogen Sales by Company (2016-2021)
11.1.2 India Human Fibrinogen Revenue by Company (2016-2021)
11.2 India Human Fibrinogen Sales Breakdown by Type
11.2.1 India Human Fibrinogen Sales Breakdown by Type (2016-2021)
11.2.2 India Human Fibrinogen Sales Breakdown by Type (2022-2027)
11.3 India Human Fibrinogen Sales Breakdown by Application
11.3.1 India Human Fibrinogen Sales Breakdown by Application (2016-2021)
11.3.2 India Human Fibrinogen Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Fibrinogen Business
12.1 CSL Behring
12.1.1 CSL Behring Corporation Information
12.1.2 CSL Behring Business Overview
12.1.3 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Behring Human Fibrinogen Products Offered
12.1.5 CSL Behring Recent Development
12.2 LFB Group
12.2.1 LFB Group Corporation Information
12.2.2 LFB Group Business Overview
12.2.3 LFB Group Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.2.4 LFB Group Human Fibrinogen Products Offered
12.2.5 LFB Group Recent Development
12.3 Shanghai RAAS Blood Products
12.3.1 Shanghai RAAS Blood Products Corporation Information
12.3.2 Shanghai RAAS Blood Products Business Overview
12.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Shanghai RAAS Blood Products Human Fibrinogen Products Offered
12.3.5 Shanghai RAAS Blood Products Recent Development
12.4 Jiangxi Boya Bio-Pharmaceutical
12.4.1 Jiangxi Boya Bio-Pharmaceutical Corporation Information
12.4.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
12.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Products Offered
12.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Development
12.5 Hualan Biological Engineering
12.5.1 Hualan Biological Engineering Corporation Information
12.5.2 Hualan Biological Engineering Business Overview
12.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hualan Biological Engineering Human Fibrinogen Products Offered
12.5.5 Hualan Biological Engineering Recent Development
12.6 Harbin Pacific Biopharmaceutical
12.6.1 Harbin Pacific Biopharmaceutical Corporation Information
12.6.2 Harbin Pacific Biopharmaceutical Business Overview
12.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Products Offered
12.6.5 Harbin Pacific Biopharmaceutical Recent Development
12.7 GREEN CROSS
12.7.1 GREEN CROSS Corporation Information
12.7.2 GREEN CROSS Business Overview
12.7.3 GREEN CROSS Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GREEN CROSS Human Fibrinogen Products Offered
12.7.5 GREEN CROSS Recent Development
12.8 Shanghai XinXing Medical
12.8.1 Shanghai XinXing Medical Corporation Information
12.8.2 Shanghai XinXing Medical Business Overview
12.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Shanghai XinXing Medical Human Fibrinogen Products Offered
12.8.5 Shanghai XinXing Medical Recent Development
12.9 Octapharma
12.9.1 Octapharma Corporation Information
12.9.2 Octapharma Business Overview
12.9.3 Octapharma Human Fibrinogen Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Octapharma Human Fibrinogen Products Offered
12.9.5 Octapharma Recent Development
13 Human Fibrinogen Manufacturing Cost Analysis
13.1 Human Fibrinogen Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Fibrinogen
13.4 Human Fibrinogen Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Fibrinogen Distributors List
14.3 Human Fibrinogen Customers
15 Market Dynamics
15.1 Human Fibrinogen Market Trends
15.2 Human Fibrinogen Drivers
15.3 Human Fibrinogen Market Challenges
15.4 Human Fibrinogen Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Fibrinogen Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Fibrinogen Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Fibrinogen Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Fibrinogen Sales (Kg) by Region (2016-2021)
Table 5. Global Human Fibrinogen Sales Market Share by Region (2016-2021)
Table 6. Global Human Fibrinogen Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Fibrinogen Revenue Share by Region (2016-2021)
Table 8. Global Human Fibrinogen Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Human Fibrinogen Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Fibrinogen Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Fibrinogen Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Fibrinogen Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Human Fibrinogen Sales Share by Company (2016-2021)
Table 14. Global Human Fibrinogen Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Fibrinogen Revenue Share by Company (2016-2021)
Table 16. Global Human Fibrinogen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Fibrinogen as of 2020)
Table 17. Global Human Fibrinogen Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Human Fibrinogen Manufacturing Sites and Area Served
Table 19. Manufacturers Human Fibrinogen Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Fibrinogen Sales (Kg) by Type (2016-2021)
Table 22. Global Human Fibrinogen Sales Share by Type (2016-2021)
Table 23. Global Human Fibrinogen Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Fibrinogen Price (USD/Kg) by Type (2016-2021)
Table 25. Global Human Fibrinogen Sales Share by Type (2022-2027)
Table 26. Global Human Fibrinogen Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Fibrinogen Revenue Share by Type (2022-2027)
Table 28. Global Human Fibrinogen Price (USD/Kg) by Type (2022-2027)
Table 29. Global Human Fibrinogen Sales (Kg) by Application (2016-2021)
Table 30. Global Human Fibrinogen Sales Share by Application (2016-2021)
Table 31. Global Human Fibrinogen Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Fibrinogen Price (USD/Kg) by Application (2016-2021)
Table 33. Global Human Fibrinogen Sales (Kg) by Application (2022-2027)
Table 34. Global Human Fibrinogen Sales Share by Application (2022-2027)
Table 35. Global Human Fibrinogen Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Fibrinogen Revenue Share by Application (2022-2027)
Table 37. Global Human Fibrinogen Price (USD/Kg) by Application (2022-2027)
Table 38. North America Human Fibrinogen Sales (Kg) by Company (2016-2021)
Table 39. North America Human Fibrinogen Sales Market Share by Company (2016-2021)
Table 40. North America Human Fibrinogen Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Fibrinogen Revenue Market Share by Company (2016-2021)
Table 42. North America Human Fibrinogen Sales by Type (2016-2021) & (Kg)
Table 43. North America Human Fibrinogen Sales Market Share by Type (2016-2021)
Table 44. North America Human Fibrinogen Sales by Type (2022-2027) & (Kg)
Table 45. North America Human Fibrinogen Sales Market Share by Type (2022-2027)
Table 46. North America Human Fibrinogen Sales by Application (2016-2021) & (Kg)
Table 47. North America Human Fibrinogen Sales Market Share by Application (2016-2021)
Table 48. North America Human Fibrinogen Sales by Application (2022-2027) & (Kg)
Table 49. North America Human Fibrinogen Sales Market Share by Application (2022-2027)
Table 50. Europe Human Fibrinogen Sales (Kg) by Company (2016-2021)
Table 51. Europe Human Fibrinogen Sales Market Share by Company (2016-2021)
Table 52. Europe Human Fibrinogen Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Fibrinogen Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Fibrinogen Sales by Type (2016-2021) & (Kg)
Table 55. Europe Human Fibrinogen Sales Market Share by Type (2016-2021)
Table 56. Europe Human Fibrinogen Sales by Type (2022-2027) & (Kg)
Table 57. Europe Human Fibrinogen Sales Market Share by Type (2022-2027)
Table 58. Europe Human Fibrinogen Sales by Application (2016-2021) & (Kg)
Table 59. Europe Human Fibrinogen Sales Market Share by Application (2016-2021)
Table 60. Europe Human Fibrinogen Sales by Application (2022-2027) & (Kg)
Table 61. Europe Human Fibrinogen Sales Market Share by Application (2022-2027)
Table 62. China Human Fibrinogen Sales (Kg) by Company (2016-2021)
Table 63. China Human Fibrinogen Sales Market Share by Company (2016-2021)
Table 64. China Human Fibrinogen Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Fibrinogen Revenue Market Share by Company (2016-2021)
Table 66. China Human Fibrinogen Sales by Type (2016-2021) & (Kg)
Table 67. China Human Fibrinogen Sales Market Share by Type (2016-2021)
Table 68. China Human Fibrinogen Sales by Type (2022-2027) & (Kg)
Table 69. China Human Fibrinogen Sales Market Share by Type (2022-2027)
Table 70. China Human Fibrinogen Sales by Application (2016-2021) & (Kg)
Table 71. China Human Fibrinogen Sales Market Share by Application (2016-2021)
Table 72. China Human Fibrinogen Sales by Application (2022-2027) & (Kg)
Table 73. China Human Fibrinogen Sales Market Share by Application (2022-2027)
Table 74. Japan Human Fibrinogen Sales (Kg) by Company (2016-2021)
Table 75. Japan Human Fibrinogen Sales Market Share by Company (2016-2021)
Table 76. Japan Human Fibrinogen Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Fibrinogen Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Fibrinogen Sales by Type (2016-2021) & (Kg)
Table 79. Japan Human Fibrinogen Sales Market Share by Type (2016-2021)
Table 80. Japan Human Fibrinogen Sales by Type (2022-2027) & (Kg)
Table 81. Japan Human Fibrinogen Sales Market Share by Type (2022-2027)
Table 82. Japan Human Fibrinogen Sales by Application (2016-2021) & (Kg)
Table 83. Japan Human Fibrinogen Sales Market Share by Application (2016-2021)
Table 84. Japan Human Fibrinogen Sales by Application (2022-2027) & (Kg)
Table 85. Japan Human Fibrinogen Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Fibrinogen Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Human Fibrinogen Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Fibrinogen Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Fibrinogen Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Fibrinogen Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Human Fibrinogen Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Fibrinogen Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Human Fibrinogen Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Fibrinogen Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Human Fibrinogen Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Fibrinogen Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Human Fibrinogen Sales Market Share by Application (2022-2027)
Table 98. India Human Fibrinogen Sales (Kg) by Company (2016-2021)
Table 99. India Human Fibrinogen Sales Market Share by Company (2016-2021)
Table 100. India Human Fibrinogen Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Fibrinogen Revenue Market Share by Company (2016-2021)
Table 102. India Human Fibrinogen Sales by Type (2016-2021) & (Kg)
Table 103. India Human Fibrinogen Sales Market Share by Type (2016-2021)
Table 104. India Human Fibrinogen Sales by Type (2022-2027) & (Kg)
Table 105. India Human Fibrinogen Sales Market Share by Type (2022-2027)
Table 106. India Human Fibrinogen Sales by Application (2016-2021) & (Kg)
Table 107. India Human Fibrinogen Sales Market Share by Application (2016-2021)
Table 108. India Human Fibrinogen Sales by Application (2022-2027) & (Kg)
Table 109. India Human Fibrinogen Sales Market Share by Application (2022-2027)
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Business Overview
Table 112. CSL Behring Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. CSL Behring Human Fibrinogen Product
Table 114. CSL Behring Recent Development
Table 115. LFB Group Corporation Information
Table 116. LFB Group Description and Business Overview
Table 117. LFB Group Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. LFB Group Human Fibrinogen Product
Table 119. LFB Group Recent Development
Table 120. Shanghai RAAS Blood Products Corporation Information
Table 121. Shanghai RAAS Blood Products Description and Business Overview
Table 122. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Shanghai RAAS Blood Products Human Fibrinogen Product
Table 124. Shanghai RAAS Blood Products Recent Development
Table 125. Jiangxi Boya Bio-Pharmaceutical Corporation Information
Table 126. Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
Table 127. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product
Table 129. Jiangxi Boya Bio-Pharmaceutical Recent Development
Table 130. Hualan Biological Engineering Corporation Information
Table 131. Hualan Biological Engineering Description and Business Overview
Table 132. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Hualan Biological Engineering Human Fibrinogen Product
Table 134. Hualan Biological Engineering Recent Development
Table 135. Harbin Pacific Biopharmaceutical Corporation Information
Table 136. Harbin Pacific Biopharmaceutical Description and Business Overview
Table 137. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Harbin Pacific Biopharmaceutical Human Fibrinogen Product
Table 139. Harbin Pacific Biopharmaceutical Recent Development
Table 140. GREEN CROSS Corporation Information
Table 141. GREEN CROSS Description and Business Overview
Table 142. GREEN CROSS Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. GREEN CROSS Human Fibrinogen Product
Table 144. GREEN CROSS Recent Development
Table 145. Shanghai XinXing Medical Corporation Information
Table 146. Shanghai XinXing Medical Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Shanghai XinXing Medical Description and Business Overview
Table 148. Shanghai XinXing Medical Human Fibrinogen Product
Table 149. Shanghai XinXing Medical Recent Development
Table 150. Octapharma Corporation Information
Table 151. Octapharma Human Fibrinogen Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Octapharma Description and Business Overview
Table 153. Octapharma Human Fibrinogen Product
Table 154. Octapharma Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Human Fibrinogen Distributors List
Table 158. Human Fibrinogen Customers List
Table 159. Human Fibrinogen Market Trends
Table 160. Human Fibrinogen Market Drivers
Table 161. Human Fibrinogen Market Challenges
Table 162. Human Fibrinogen Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Fibrinogen Product Picture
Figure 2. Global Human Fibrinogen Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Fibrinogen Sales Market Share by Application in 2021 & 2027
Figure 6. Congenital Fibrinogen Deficiency Examples
Figure 7. Surgical Procedures Examples
Figure 8. Global Human Fibrinogen Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Human Fibrinogen Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Human Fibrinogen Sales (Kg) Growth Rate (2016-2027)
Figure 11. Global Human Fibrinogen Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Human Fibrinogen Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Human Fibrinogen Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Human Fibrinogen Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Human Fibrinogen Sales (Kg) Growth Rate (2016-2027)
Figure 16. Europe Human Fibrinogen Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Human Fibrinogen Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Human Fibrinogen Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Human Fibrinogen Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Human Fibrinogen Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Human Fibrinogen Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Human Fibrinogen Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Human Fibrinogen Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Human Fibrinogen Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Human Fibrinogen Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Human Fibrinogen Players Market Share by Revenue in Human Fibrinogen: 2016 & 2020
Figure 27. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Human Fibrinogen Revenue Share by Type (2016-2021)
Figure 29. Global Human Fibrinogen Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Human Fibrinogen Revenue Share by Application (2016-2021)
Figure 31. Global Human Fibrinogen Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Human Fibrinogen Sales Market Share by Type in 2020
Figure 33. North America Human Fibrinogen Sales Market Share by Application in 2020
Figure 34. Europe Human Fibrinogen Sales Market Share by Type in 2020
Figure 35. Europe Human Fibrinogen Sales Market Share by Application in 2020
Figure 36. China Human Fibrinogen Sales Market Share by Type in 2020
Figure 37. China Human Fibrinogen Sales Market Share by Application in 2020
Figure 38. Japan Human Fibrinogen Sales Market Share by Type in 2020
Figure 39. Japan Human Fibrinogen Sales Market Share by Application in 2020
Figure 40. Southeast Asia Human Fibrinogen Sales Market Share by Type in 2020
Figure 41. Southeast Asia Human Fibrinogen Sales Market Share by Application in 2020
Figure 42. India Human Fibrinogen Sales Market Share by Type in 2020
Figure 43. India Human Fibrinogen Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Human Fibrinogen
Figure 46. Manufacturing Process Analysis of Human Fibrinogen
Figure 47. Human Fibrinogen Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界のヒトフィブリノーゲン濃縮物市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Fibrinogen Concentrate Market The global Human Fibrinogen Concentrate market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…- フィブリノーゲン濃縮物のグローバル市場2021 The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue rat…
- フィブリノーゲンのグローバル市場2021 Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is lice…
- フィブリノゲンのグローバル市場調査 2019年 The global Fibrinogen market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fibrinogen volume and value at global level, regional level and company level. From a global perspective, this report represents…
- ヒト血液凝固因子VIIのグローバル市場2021 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…